Previous Article | Next Article ![]()
Journal of Virology, February 2000, p. 1794-1800, Vol. 74, No. 4
Department of Molecular Virology and Host
Defense, SmithKline Beecham Pharmaceuticals, Collegeville,
Pennsylvania 19426-0989
Received 16 July 1999/Accepted 6 November 1999
Helicase/nucleoside triphosphatase (NTPase) motifs have been
identified in many RNA virus genomes. Similarly, all the members of the
Flaviviridae family contain conserved helicase/NTPase
motifs in their homologous NS3 proteins. Although this suggests that this activity plays a critical role in the viral life cycle, the precise role of the helicase/NTPase in virus replication or whether it
is essential for virus replication is still unknown. To determine the
role of the NS3 helicase/NTPase in the viral life cycle, deletion and
point mutations in the helicase/NTPase motifs of the bovine viral
diarrhea virus (BVDV) (NADL strain) NS3 protein designed to abolish
either helicase activity alone (motif II, DEYH to
DEYA) or both NTPase and helicase activity (motif I,
GKT to GAT and deletion of motif VI) were
generated. The C-terminal domain of NS3 (BVDV amino acids 1854 to 2362)
of these mutants and wild type was expressed in bacteria, purified, and
assayed for RNA helicase and ATPase activity. These mutations behaved
as predicted with respect to RNA helicase and NTPase activities in
vitro. When engineered back into an infectious cDNA for BVDV (NADL
strain), point mutations in either the GKT or DEYH motif or deletion of motif VI yielded RNA transcripts that no longer produced infectious virus upon transfection of EBTr cells. Further analysis indicated that
these mutants did not synthesize minus-strand RNA. These findings
represent the first report unequivocably demonstrating that helicase
activity is essential for minus-strand synthesis.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The RNA Helicase and Nucleotide Triphosphatase
Activities of the Bovine Viral Diarrhea Virus NS3 Protein Are Essential
for Viral Replication
*
Corresponding author. Mailing address: Department of
Molecular Virology and Host Defense, SmithKline Beecham
Pharmaceuticals, 1250 S. Collegeville Rd., P.O. Box 5089, Collegeville,
PA 19426-0989. Phone: (610) 917-6858. Fax: (610) 917-4170. E-mail:
alfred_m_delvecchio{at}sbphrd.com.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|